| Français | ISMP (US) | Feedback |
A Review of the Evidence
Drug interactions can lead to serious adverse patient outcomes. A number of studies have demonstrated significant associations between specific drug interactions and hospitalizations associated with adverse events.
An important feature of adverse events related to drug interactions is that they are, in theory, largely preventable. In most cases therapeutic alternatives are available so that a significant interaction can be avoided. In practice, however, recognition and management of potential drug interactions is not optimal. Interventions such as electronic screening systems and practitioner education can help, but require proper implementation and oversight to be effective.
Recently, a number of population-based studies have demonstrated significant associations between specific drug interactions and hospitalizations. This is a new development in determining the clinical impact of specific drug interactions. This one hour webinar will review these studies and discuss some potential strategies for applying the evidence to prevent hospitalizations due to drug interactions.
Learning Objectives:
At the conclusion of this webinar, participants will be able to identify:
- the current approaches to prevention of significant drug interactions,
- drug interaction pairs shown to be associated with an increased likelihood of hospitalization, and
- possible strategies to prevent hospitalization due to drug interactions.
| Audience: | Pharmacists, nurses, physicians, senior leadership and information systems teams involved in the design and maintenance of drug interaction screening systems in healthcare facilities |
| Date: | December 14, 2011 |
| Time: |
9:00 am – 10:00 am PST 10:00 am – 11:00 am MST 11:00 am – 12:00 pm CST 12:00 pm – 1:00 pm EST 1:00 pm – 2:00 pm AST 1:30 pm – 2:30 pm NST Time zone map |
| Duration: | 1 hour |
| Cost: |
• Webinar only $95 (per telephone connection plus applicable HST/GST) • Webinar plus DVD $174 (per telephone connection plus applicable HST/GST) • DVD only $95 + (plus applicable HST/GST) For registration information, please select the ‘Registration’ tab near the top of the screen. |
| Presenter: |
Roger Cheng
Project Leader, ISMP Canada |
Contact Us: webinars@ismp–canada.org
A Review of the Evidence
Presenter
|
Roger Cheng, RPh, BScPhm, PharmD
|
Background
Drug interactions can lead to serious adverse patient outcomes. A number of studies have demonstrated significant associations between specific drug interactions and hospitalizations associated with adverse events.
An important feature of adverse events related to drug interactions is that they are, in theory, largely preventable. In most cases therapeutic alternatives are available so that a significant interaction can be avoided. In practice, however, recognition and management of potential drug interactions is not optimal. Interventions such as electronic screening systems and practitioner education can help, but require proper implementation and oversight to be effective.
Recently, a number of population-based studies have demonstrated significant associations between specific drug interactions and hospitalizations. This is a new development in determining the clinical impact of specific drug interactions. This one hour webinar will review these studies and discuss some potential strategies for applying the evidence to prevent hospitalizations due to drug interactions.
Contact Us
|
Mail:
|
ISMP Canada 4711 Yonge Street, Suite 501 Toronto, ON M2N 6K8 |
|
Email:
|
webinars@ismp-canada.org |
|
Phone:
|
416–733–3131 ext.0 |
|
Toll Free:
|
1–866–544–7672 ext.0 |
|
Fax:
|
416–733–1146 |
